Trial shows promise of mRNA vaccines in treating pancreatic cancer

A recent study found that mRNA-based vaccines may help to delay the recurrence of pancreatic cancer by generating long-lasting immune responses. 

Read the full post on Becker's Hospital Review | Healthcare News & Analysis